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Background and aim: Management of health issues 
presented by newly arrived migrants is often lim-
ited to communicable diseases even though other 
health issues may be more prevalent. We report the 
results of infectious disease screening proposed to 
462 recently-arrived asylum seekers over 14 years of 
age in Verona province between April 2014 and June 
2015.  Methods:  Screening for latent tuberculosis (TB) 
was performed via tuberculin skin test (TST) and/
or QuantiFERON-TB Gold in-tube assay and/or chest 
X-ray. An ELISA was used to screen for syphilis. Stool 
microscopy was used to screen for helminthic infec-
tions, and serology was also used for strongyloidia-
sis and schistosomiasis. Screening for the latter also 
included urine filtration and microscopy. Results: Most 
individuals came from sub-Saharan Africa (77.5%), 
with others coming from Asia (21.0%) and North 
Africa (1.5%). The prevalence of viral diseases/mark-
ers of human immunodeficiency virus (HIV) infection 
was 1.3%, HCV infection was 0.85% and hepatitis B 
virus surface antigen was 11.6%. Serological tests for 
syphilis were positive in 3.7% of individuals. Of 125 
individuals screened for TB via the TST, 44.8% were 
positive and of 118 screened via the assay, 44.0% 
were positive. Of 458 individuals tested for strongyloi-
diasis, 91 (19.9%) were positive, and 76 of 358 (21.2%) 
individuals from sub-Saharan Africa were positive for 
schistosomiasis.  Conclusions:  The screening of viral 
diseases is questionable because of low prevalence 
and/or long-term, expensive treatments. For opposing 
reasons, helminthic infections are probably worth to 
be targeted by screening strategies in asylum seekers 
of selected countries of origin.
Introduction 
In 2015, there were an estimated 244 million inter-
national migrants, representing 3% of the global 
population [1]. In recent years, the flow of migrants 
from Northern Africa to the coasts of southern Italy via 
the Central Mediterranean migration route has been 
constantly increasing, reaching 181,126 migrants in 
2016 [2]. The term migrant encompasses a heterogene-
ous population that includes refugees, asylum seekers 
and economic migrants that come from countries with 
large differences in the prevalence of diseases [3]. Well-
defined screening protocols specifically addressing 
migrants from different geographical areas are impor-
tant to detecting some infectious diseases, regardless 
of whether or not they are causing symptoms. However, 
the main aim of European health authorities is avoiding 
the possible spreading of infectious diseases to local 
populations [4]. Migrants are therefore mostly screened 
for active [5] and latent tuberculosis (TB) [6,7], human 
immunodeficiency virus (HIV) infection and chronic 
viral hepatitis [8,9]. Almost no action aside from local 
initiatives is taken towards other infections such as 
parasitic diseases although these often have a higher 
prevalence than the aforementioned infections [10-14]. 
Moreover, their treatment is exceedingly shorter and 
cheaper than treatment for HIV and viral hepatitis, and 
can prevent severe and even fatal complications in the 
affected individuals [12,15-17].
In general, the inclusion of infections in a screening 
programme should take different issues into account. 
Cost-effectiveness is one of them, but other perspec-
tives should also be considered, such as the heteroge-
neity of migrant populations in terms of prevalence of 
specific health problems. Studies have been performed 
on migrants attending clinics for any reason [13,18], but 
data from these are not reliable enough to estimate the 
real prevalence in the general migrant population.
49www.eurosurveillance.org
The aim of this study is to estimate the prevalence of 
a series of infectious diseases, communicable and 
non-communicable, in a cohort of asylum seekers that 
recently arrived in Europe and temporarily residing in a 
series of refugee shelters in Verona province, northern 
Italy.
Methods
Study population and setting
This retrospective observational study includes report-
ing data from infectious disease screening activities 
systematically carried out from April 2014 to June 2015 
in 14 refugee shelters in Verona province, northern Italy. 
The shelters are managed by different cooperatives 
that receive financial support from the Italian govern-
ment. The study population included asylum seekers 
over 14 years of age arriving in the last 6 months. Two 
infectious diseases physicians were in charge of the 
screening activities and regularly went to the shel-
ters to check on the health of newly arrived asylum 
seekers. Those requiring specific workup/treatment 
were referred either to the local health unit, Azienda 
Sanitaria Locale (ASL), or to a hospital depending on 
the level of diagnostic workup/treatment required. 
Extended screening for infectious diseases was offered 
to all asylum seekers referred by the physicians to the 
Centre for Tropical Diseases (CTD) in Negrar, Verona, for 
the blood sampling. Those who accepted were asked to 
sign an informed consent form, with parents or a legal 
guardian signing for individuals less than 18 years of 
age. Demographic data were registered according to 
the documents issued by the prefectures where the 
individuals applied for asylum.
Screening strategy
In addition to the full blood cell count (FBC), some 
diagnostic tests for specific infections were proposed:
Viral diseases/infections
Screening for HIV infection was performed with an ELISA 
(Beckman Coulter, Inc.), and a Western blot (Fujirebio 
Figure 
Flow of extended screening for infectious diseases among asylum seekers from Africa and Asia, Verona province, Italy, 
April 2014–June 2015
Asylum seekers oﬀered screening 
 (n = 481) 
Asylum seekers refusing consent 
(n = 19) 
Asylum seekers screened
(n = 462) 
 Individuals from sub-Saharan Africa 
(n = 358)
Sex: 338 (94.4%) male
Median age: 23 years (IQR: 20–27)
Individuals from Asia
(n = 97) 
Sex: 97 (100%) male
Median age: 24 years (IQR: 21.5–28)
Individuals from North Africa
(n = 7) 
 Sex: 7 (100%) male
Median age: 24 years (IQR: 21.5–29.5)
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Diagnostics) was used as confirmatory test. Depending 
on the ASL of reference, some individuals were tested 
for antibodies against hepatitis B virus (HBV), namely 
the HBV core antibody (anti-HBc) and the HBV surface 
antibody (anti-HBs) respectively, although most indi-
viduals were tested for HBV surface antigen (HBsAg). 
All assays for HBV were ELISA (Beckmann Coulter, Inc.). 
Antibodies against hepatitis C virus were also detected 
with ELISA (Beckman Coulter, Inc.).
Bacterial diseases
Screening for syphilis was conducted by screen-
ing for  Treponema pallidum  using an IgG ELISA test 
(Fujirebio Diagnostics) and a rapid plasma reagin, 
while the Treponema pallidum haemaglutination assay 
(TPHA) was used for confirmatory tests. Screening for 
TB was conducted with tuberculin skin test (TST), and/
or QuantiFERON-TB Gold in-tube assay (QFT-GIT), and/
or chest X-ray, depending on the ASL.
Helminthic infections
Helminthic infections were screened with the follow-
ing methods: stool examination for ova and parasites 
(O and P) after formol-ether concentration with three 
samples being collected on different days, urine exam-
ination after micropore filtration for  Schistosoma hae-
matobium  (only for asylum seekers from sub-Saharan 
Africa), serology for  Schistosoma  spp. (Schistosoma 
mansoni ELISA kit, Bordier Affinity Products SA, 
Crissier, Switzerland) and  Strongyloides stercora-
lis (in-house immunofluorescence test, IFAT).
All individuals positive for any screening test were 
referred to the CTD for the appropriate clinical manage-
ment. The results were then entered anonymously in an 
Excel database.
Statistical analysis
Descriptive statistics were used to describe the char-
acteristics of the entire cohort. Categorical variables 
were reported as frequencies and proportions, while 
Table 1
Regions and countries of origin of asylum seekers, Verona province, Italy, April 2014–June 2015
Region Country Number of asylum seekers (n)
Percentage within region 
 
(%; 95% CI)
Sub-Saharan Africa
Angola 1 0.3 (0.1–1.6)
Burkina Faso 8 2.2 (1.1–4.3)
Cameroon 3 0.8 (0.3–2.4)
Congo 1 0.3 (0.1–1.6)
Côte d’Ivoire 24 6.7 (4.5–9.8)
Eritrea 6 1.7 (0.7–3.6)
The Gambia 40 11.2 (8.3–14.8)
Ghana 39 10.9 (8.0–14.5)
Guinea 4 1.1 (0.4–2.8)
Guinea-Bissau 4 1.1 (0.4–2.8)
Mali 103 28.8 (24.3–33.7)
Nigeria 81 22.6 (18.6–27.2)
Senegal 28 7.8 (5.5–11.0)
Somalia 14 3.9 (2.3–6.5)
Sudan 2 0.6 (0.2–2.0)
Total 358 100.0
Asia
Afghanistan 1 1.0 (0.2–5.6)
Bahrain 1 1.0 (0.2–5.6)
Bangladesh 38 39.2 (30.1–49.1)
Nepal 1 1.0 (0.2–5.6)
Pakistan 54 55.7 (45.8–65.2)
Palestine 1 1.0 (0.2–5.6)
Sri Lanka 1 1.0 (0.2–5.6)
Total 97 100.0
North Africa
Morocco 6 85.7 (48.7–97.4)
Tunisia 1 14.3 (2.6–51.3)
Total 7 100.0
CI: confidence interval.
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quantitative variables were presented as medians 
with interquartile ranges (IQR). We also investigated 
associations between age, infections and eosinophilia 
through Student’s t-test and univariate logistic mod-
els. Lastly, we fitted a multivariate logistic regression 
model to assess a possible association of age and of 
parasitic infections with the probability of eosinophilia. 
Statistical analyses were performed using Epi Info pro-
gramme version 3.5 [19] and R version 3.3.3 [20].
Ethical clearance
The study protocol received ethical clearance from the 
ethics committee for clinical trials in the provinces of 
Verona and Rovigo (Comitato Etico per la sperimentazi-
one Clinica delle Province di Verona e Rovigo) on 10 
May 2017 (protocol number 24126).
Results
The screening was offered to 481 asylum seekers but 
as 19 refused, 462 individuals were screened and 
included in this analysis (Figure). The median age was 
24 years (IQR: 20–28) and 95.7% (n = 442) were male. 
Most came from sub-Saharan Africa (77.5%; n = 358), 
with others originating from Asia (21%; n = 97) or from 
North Africa (1.5%; n = 7) (Table 1). Of note, 22.3% of 
individuals came from Mali.
In the whole cohort, the median eosinophil count was 
210/µL (IQR: 120–420), and 144 individuals (31.2%) 
presented a eosinophil count ≥ 350/µL (i.e. had eosin-
ophilia). In relation to the regions, eosinophilia was 
present in 105 of 358 (29.3%) individuals from sub-
Saharan Africa (median eosinophil count: 550/µL; 
IQR: 450–740), 38 of 97 (39.2%) individuals from Asia 
(median eosinophil count: 605/µL; IQR: 465–930), and 
one of seven individuals from North Africa (eosinophil 
count: 580/µL). In the Asia subgroup, eosinophilia was 
present in 18 of 38 individuals from Bangladesh and 18 
of 54 individuals from Pakistan.
Viral diseases/infections
Six of 455 individuals (1.3%) screened were positive for 
HIV infection. They were all from sub-Saharan Africa: 
two from Côte d’Ivoire, two from The Gambia, one from 
Mali and one from Guinea-Bissau. The percentage of 
HIV-positive individuals of all of individuals screened 
from sub-Saharan Africa was 1.7% (6/353). Of the 457 
people screened for HBV infection by being tested for 
HBsAg, 53 (11.6%) tested positive. Most (n = 49) came 
from sub-Saharan Africa, representing 13.8% of people 
from that region who underwent this screening test (n 
= 355). The remaining four individuals came from Asia, 
representing 4.2% of people from that region who were 
screened (n = 95). In addition, 99 of 338 individuals 
(29.3%) screened for anti-HBs were positive while 107 
of 172 individuals (62.2%) screened for anti-HBc were 
positive. Of the 118 individuals tested for HCV infec-
tion, only one person (0.85%) tested positive.
Bacterial diseases
In terms of screening for syphilis, 4.5% of individuals 
from sub-Saharan Africa were positive (16/352), and 
1.0% of individuals from Asia were positive (1/95), 
whereas none of the seven individuals from North 
Africa were positive. The results of the screening tests 
for TB are summarised in  Table 2. In addition to the 
data reported in the table, an additional 42 individu-
als were tested with both TST and QFT-GIT: 16 were 
negative to both methods, 16 were positive to both, 
three were positive to TST only and seven were posi-
tive to QFT-GIT only. Two-hundred and sixty individu-
als underwent a chest X-ray, which was normal in 217 
(83.5%) cases. Ninety-four people were screened for 
latent TB exclusively with chest X-ray, and eight (8.5%) 
of them presented any pulmonary abnormalities. Forty-
nine individuals with a positive TST underwent a chest 
X-ray, and nine presented abnormal pulmonary find-
ings, whereas 30 individuals with a positive QFT-GIT 
underwent a chest X-ray and seven had pulmonary 
abnormalities.
Table 2
Results of screening tests for latent tuberculosis, Verona province, Italy, April 2014–June 2015
Screening test
Totala Sub-Saharan Africa Asia North Africa
Tested 
individuals
Positive 
individuals
Positive/tested 
individuals
Positive/tested 
individuals
Positive/tested 
individuals
N n % n/N % n/N % n/N %
TST 125 56 44.8 37/82 45.1 16/38 42.1 3/5 60
QFT-GIT 118 52 44.0 45/94 47.9 7/24 29.2 0/0 0
Chest X-rayb 260 35 14.5 27/193 13.9 7/61 11.5 1/6 16.7
QFT-GIT: QuantiFERON-TB Gold in-tube assay; TST: tuberculin skin test.
a In addition to the data reported in the table, an additional 42 individuals were tested with both TST and QFT-GIT: 16 were negative to both 
methods, 16 were positive to both, 3 were positive to TST only and 7 were positive to QFT-GIT only.
b Positive chest X-rays were considered those with any pulmonary abnormalities, including calcified nodules. Abnormalities of other 
anatomical sites, e.g. heart, vessels, were not included in this analysis.
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Helminthic infections
A stool sample was provided by 270 of 358 (75.4%) 
individuals coming from sub-Saharan Africa and 79 
of 97 (81.4%) individuals coming from Asia; thus, no 
significant association was observed between region 
and will to provide a stool sample (chi-squared test, 
p value = 0.285). Among the seven individuals coming 
from North Africa, three did not supply a stool sample.
Table 3  shows the main results of stool examination, 
in relation to region of origin of the asylum seekers. In 
addition to the data reported in the table, urine was 
examined for O and P in 96 of the individuals from sub-
Saharan Africa, and 20 (20.8%) presented  S. haema-
tobium eggs. Of the four individuals from North Africa 
that supplied stool samples, all were negative for O 
and P. Screening with S. stercoralis serology was done 
for 458 individuals, 91 (19.9%) of whom were positive. 
Of the latter, 14 (32.6%) had positive stool microscopy 
for S. stercoralis  larvae. One additional individual had 
positive microscopy and negative serology. Hence, 92 
of 458 (20.1%) individuals tested were positive to any 
test for S. stercoralis, and 15 (3.3%) had larvae in stool.
In terms of regions, 64 of 358 (17.9%) people from 
sub-Saharan Africa were positive to any test for  S. 
stercoralis(serology and/or stool microscopy), whereas 
28 of 97 (28.9%) individuals from Asia were. Of 358 
individuals from sub-Saharan Africa tested, 76 (21.2%) 
were positive for at least one test for Schistosoma spp. 
(urine microscopy or stool microscopy or serology). 
Three of them had negative serology, whereas 32 
individuals had positive serology and negative 
detection of Schistosoma spp. eggs.
Table 4  displays a summary of the univariate and 
multivariate analyses regarding the association 
between eosinophilia and either age or the main 
helminthiasis in the entire cohort of asylum seekers, as 
well as in the sub-Saharan African and Asian subgroups. 
As expected, people with eosinophilia were more likely 
to be infected with S. stercoralis, Schistosoma spp. and 
hookworm (Ancylostoma duodenale and Necator amer-
icanus). Adjusted ORs highlight a strong association 
between helminthic infections and the probability 
of presenting eosinophilia, both in the entire cohort 
and in individuals from sub-Saharan Africa. In con-
trast, the presence of S. stercoralis was not associated 
with eosinophilia in individuals from Asia (adjusted 
odds ratio (OR): 0.76, 95% confidence interval (CI): 
0.25–2.13).
Discussion
Infectious diseases are not the main problem affecting 
individuals that are part of the large, current wave of 
migration to Italy, often through the perilous Central 
Mediterranean route. Those who survive the journey 
almost invariably have, at least in our experience with 
a large number of asylum seekers, a history of expe-
riencing physical, sexual and/or psychological harass-
ment, violence and often torture. A recently published 
review underlines the role of traumatic experiences 
during the migration process on various aspects of 
health and health conditions [21]. Mental and psy-
chosocial diseases, including depression and anxi-
ety disorder, as well as the consequences of physical 
traumatism, are probably the first health priority to be 
dealt with [22,23].
However, attention should also be paid to infectious 
diseases, especially because of concerns about infec-
tion spreading to the local population that are often 
unfounded. In Italy therefore, the only screening for-
mally indicated so far includes a clinical assessment 
for scabies and one for clinical and/or latent TB (pro-
tocols for the latter are not uniform). Many individuals 
are also screened for HIV, although there is no formal 
country-wide protocol for this infection, and a number 
are also screened for hepatitis B and C, with different, 
informal protocols.
At the CTD we applied, as a pilot initiative within the 
Veneto Region, an extended screening in Verona prov-
ince that included screening for neglected helminthic 
infections. These are not a cause of concern for the 
local population, but may place a heavy clinical burden, 
Table 3
Results of stool examination for ova and parasitesa, Verona province, Italy, April 2014–June 2015
Region
Individuals screened 
by stool microscopy
Positive 
for Strongyloides 
stercoralis larvae
Positive 
for Schistosoma 
mansoni eggs
Positive for 
hookwormb eggs
Positive 
for Ascaris 
lumbricoides 
eggs
Positive 
for Trichuris 
trichiura eggs
Positive 
for other 
parasitesa
n n % n % n % n % n % n %
Sub-
Saharan 
Africa 
(n = 358)
270 9 3.3 19 7.0 34 12.6 2 0.7 4 1.5 80 29.6
Asia 
(n = 97) 79 6 7.6 0 0 13 16.5 2 2.5 9 11.4 17 21.5
a Reporting is focused on helminths determined to be clinically relevant, such as soil-transmitted helminths. Some other parasites, 
both helminths and protozoa, might not have a clinical relevance and are included in the other parasites group (e.g. Hymenolepis 
nana and Endolimax nana).
b Includes Ancylostoma duodenale and Necator americanus.
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even after many years, on infected individuals, includ-
ing life-threatening complications of strongyloidiasis 
or schistosomiasis. The prevalence of neglected para-
sitic infections was high. These are most often asymp-
tomatic, and therefore may only be detected with a 
specially designed screening, and they are never con-
sidered a priority as they cause no harm to the autoch-
thonous population.
As far as HIV/AIDS is concerned, the prevalence in indi-
viduals from sub-Saharan Africa is low compared to 
the helminthic infections, and no individual from North 
Africa or Asia was found to be infected. The same is 
even more true for HCV infection as there was only 
one infected individual in the whole study population. 
On the contrary, prevalence of HBV infection was high 
and similar to that found by studies on other migrant 
populations [13,24]. Latent TB was high in our study 
population, which is similar to findings reported in 
recent papers from other European countries [13,24]. 
Is an extended screening such as the one we carried 
out worthwhile? A definitive answer would need to be 
based on a formal cost-effectiveness study, and that 
was well beyond the scope of this paper. However, 
we believe that our results certainly question the use-
fulness of screening for HCV infection because of its 
low prevalence in combination with extremely high-
cost treatment that has limited its use to advanced 
stages of the disease. The utility of HIV screening is 
also debatable, as is that of HBV infection. Both imply 
treatments that, besides being very expensive, require 
a long-term management and a treatment compliance 
that is particularly difficult to obtain in this often very 
mobile population. The same problem, though to a 
lesser extent, concerns latent TB screening: shorter 
courses, i.e. 3 months, of treatment are available and 
some local health units in our region have been able to 
achieve 80% or more of treatment success (personal 
communication, C. Postiglione April 2018). However, 
others simply refrain from providing any treatment as 
they feel unable to ensure sufficient compliance and 
follow-up in this group of individuals. We argue that 
if treatment is not offered and adequate conditions 
to guarantee compliance cannot be ensured through 
directly observed treatment (DOT) or a similar strategy, 
latent TB screening is not a good use of resources and 
should not be proposed.
Helminthic infections can also potentially cause serious 
health consequences for infected individuals, however, 
person-to-person transmission does not represent an 
issue and treatment is comparatively straight forward. 
Like our study, other studies reported high prevalence 
of some helminths targeted by the screening of asymp-
tomatic individuals [14,25]. While the implementation 
of screening activities for these infections sometimes 
faces obstacles, such as refusal to supply biological 
samples and test limitations (low sensitivity of stool 
Table 4
Crude and adjusted odds ratios for the association between helminthic infectionsa and eosinophilia among all migrants and 
stratified by region of origin, Verona province, Italy, April 2014–June 2015
Covariate
Eosinophilia present Eosinophilia absent
Crude OR (95% CI) Adjusted OR (95% CI)b
n/N % n/N %
Total (n = 461)c,d
Age (median, IQR) 23 (20–26) 24 (20–28) 0.96 (0.93–0.99) 0.98 (0.94–1.02)
Strongyloides stercoralis 42/144 29.2 51/316 16.1 2.14 (1.33–3.41) 1.98 (1.11–3.52)
Schistosoma spp. 46/144 31.9 36/308 11.7 3.55 (2.17–5.84) 5.13 (2.93–9.18)
Hookworme 32/126 25.4 15/227 6.7 4.81 (2.53–9.53) 5.28 (2.63–11.00)
Sub-Saharan Africa (n = 357)d
Age 22 (20–26) 24 (20–28) 0.96 (0.92–1.01) 0.97 (0.91–1.01)
S. stercoralis 30/105 28.6 34/251 13.6 2.55 (1.45–4.45) 2.80 (1.37–5.79)
Schistosoma spp. 46/105 43.8 36/252 14.3 4.68 (2.78–7.93) 6.38 (3.46–12.05)
Hookworme 22/94 23.4 12/176 6.8 4.17 (1.99–9.14) 4.69 (2.02–11.22)
Asia (n = 97)f
Age 23 (19–27) 25 (21–29) 0.96 (0.89–1.02) 1.00 (0.93–1.06)
S. stercoralis 12/38 31.6 17/59 28.8 1.14 (0.46–2.75) 0.76 (0.25–2.13)
Hookworme 10/31 32.3 3/48 6.3 7.14 (1.95–34.38) 7.54 (1.95–38.10)
CI: confidence interval; IQR: interquartile range; OR: odds ratio.
a Infections were diagnosed using any of the following: urine microscopy or stool microscopy or serology.
b Adjusted for age and for the presence of other helminth infections through a multivariate logistic regression model.
c The total includes seven individuals coming from North Africa.
d The value does not include one person from the cohort (n = 462) for whom info about eosinophil count is missing.
e Includes Ancylostoma duodenale and Necator americanus.
f No Schistosoma spp. was detected in individuals from Asia so it was not possible to adjust the model for this infection.
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examination in case of  Schistosoma  spp. and  S. ster-
coralis  infections, and concerns about specificity of 
serology), treatment of these infections is short, often a 
stat dose, very effective, well tolerated and reasonably 
cheap [14]. Two studies of cost-effectiveness of the 
management of this group of diseases in immigrants 
were carried out in the United States (US) [17,26], with 
a particular focus on strongyloidiasis, concluding that 
presumptive treatment was the more cost-effective 
option, especially if provided in the country of origin 
before departure.
These studies from the US are not particularly appli-
cable to the Italian situation for several reasons. First, 
schistosomiasis was highly prevalent in our study, but, 
reflecting a different geographical origin of immigrants, 
the American studies did not consider this infection in 
their analyses. Second, treatment before migration is 
obviously not possible given that many migrants are 
arriving in Europe without having previous contact with 
authorities. Third, drug availability and cost are a major 
concern in Italy given that ivermectin and praziquan-
tel, which are used for strongyloidiasis and schistoso-
miasis, respectively, are not registered and need to be 
imported at a non-negligible cost. Fourth, by the Italian 
Constitution, every individual in Italy has the right to 
the best-available healthcare which means that any 
difference in medical approach between Italians and 
non-Italians would be discriminatory. Although offering 
screening for helminthic infections only to symptomatic 
people might presumably increase the compliance to 
diagnostic tests and treatment, this approach would 
considerably reduce asymptomatic infected individu-
als access to treatment. Also, as schistosomiasis and 
strongyloidiasis frequently lead to chronic indolent dis-
eases, such a strategy would leave the largest propor-
tion of infected individuals, asymptomatic individuals, 
at high risk of potentially-fatal complications. A half-
way measure, which also takes difficulties in obtaining 
the stool samples into consideration, might be pre-
sumptive treatment for helminthic diseases based on 
the presence of eosinophilia. This might be a particu-
larly valid option for population subgroups and/or hel-
minths where the association between helminths and 
eosinophilia proved to be strong. In comparison with 
a strategy that screens symptomatic people, a smaller 
proportion of infected individuals would be left without 
treatment. Moreover, this approach would reduce the 
costs and the logistical constraints of universal screen-
ing. However, the negative predictive value of eosino-
philia might not be sufficiently high to safely exclude 
strongyloidiasis and schistosomiasis, as suggested 
previously [14]. An in-depth cost-effectiveness analysis 
should be conducted.
In any case, the current strategy of not addressing 
neglected parasitic diseases is not acceptable.
A main limitation of this study is that the cohort of asy-
lum seekers was almost entirely composed of males so 
we could not evaluate possible, sex-related differences 
in the distribution and proportion of the same infec-
tions. Moreover, our results may not be representative 
of the situation of asylum seekers in other countries 
in Europe/other Italian settings. The main strength is 
that this paper adds to the little data available in the 
medical literature on an extensive screening of newly-
arrived asylum seekers that includes helminthic infec-
tions, regardless of whether or not clinical symptoms 
are present. We believe that our data on a cohort of 
individuals, mostly originating from sub-Saharan 
Africa, particularly contribute to filling a gap of knowl-
edge in terms of relevant helminthic infections possibly 
presented by asylum seekers in Italy. This may prove 
particularly useful as the Italian Ministry of Health 
recently issued new screening guidelines that recom-
mend the screening of asylum seekers and refugees for 
strongyloidiasis and schistosomiasis for the first time 
[27].
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